Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-10-19

FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Escitalopram Oxalate by Exelan Pharmaceuticals, indicating a change to the drug's labeling under a supplemental appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate (escitalopram oxalate)

Snippet

SUPPL AP for ESCITALOPRAM OXALATE (ESCITALOPRAM)